TVTX

47.0002.69%
EM

Eric M. Dube

President, CEO & Director

Dr. Eric M. Dube, Ph.D., serves as an Independent Director at Reneo Pharmaceuticals, Inc. since March 2021. Dr. Dube serves as President and Chief Executive Officer at Travere Therapeutics, Inc. (formerly known as Retrophin, Inc.) since January 4, 2019 and its Director since January 2019. Prior to joining Travere Therapeutics, Dr. Dube was President and head of North America at Viiv Healthcare Limited since January 2018, where he led the commercialization of pipeline assets and oversaw the governance of all pricing, strategy, policy and investment decisions for the company’s North America business. Before joining ViiV, he worked in roles of increasing leadership at GlaxoSmithKline plc, spanning critical areas, including sales, marketing, market access, medical affairs, compliance, supply chain and alliance management. During Dr. Dube’s tenure at GSK, he also led the US Oncology and Global Respiratory businesses. Dr. Dube currently serves on the Board of Directors for the Biotechnology Innovation Organization (BIO) and Biocom California. He has pharmaceutical leadership experience to head ViiV Healthcare’s operations in the US, Canada and Puerto Rico. His career at GSK in 2000 as a medical science liaison and has worked in a variety of marketing, sales, operations and strategy roles in the US, Japan and Europe. He served as vice president of managed markets for national accounts, as well as head of the oncology business unit where he oversaw multiple product launches and transformed the business model to better address emerging customer and patient needs. He then led commercial operations across the North America Pharma organization as senior vice president of strategy, planning and operations. Under his leadership, GSK Japan’s respiratory portfolio and business returned to growth. Dr. Dube served as Senior Vice President and Head, Global Respiratory Franchise of GlaxoSmithKline Pharmaceuticals plc (GSK) since June 2015 until December 2017. Dr. Dube served as Senior Vice President and Business Unit Head, Respiratory Japan of GSK since February 2013 until May 2015. During his tenure at GSK, he was the co-sponsor of the Women’s Leadership Initiative employee resource group and various diversity leadership development programs and served on the Global LGBT+ Council. He represented ViiV Healthcare on the GSK US Race and Ethnicity Council. He has earned national and global recognition. He was on Fortune magazine’s “40 Under 40: Ones to Watch” list in 2011 and was named one of 2012’s “Emerging Pharma Leaders” by Pharmaceutical Executive. He was also featured on the Financial Times’ list of “OUTstanding 100 LGBT+ Executives” in 2018. His professional focus on addressing unmet needs of patients and customers has also influenced his personal interests. He served as a founding member of the board of directors for Puentes de Salud, a non-profit that promotes the health and wellness of Philadelphia’s Latino immigrant population. Dr. Dube serves on the board of trustees for AIDS United. He is an accomplished pharmaceutical industry executive and a leader in the rare disease field. He graduated from Santa Clara University with a B.S. in Biopsychology, he earned an M.A. and Ph.D. in Psychology from Cornell University, where his studies focused on how culture, gender and ethnicity influenced resilience in the LGBTQ community. He also completed the Finance for Senior Executives program at Harvard Business School and studied four languages.

Positions